baber/WOPTO huggingface dataset:
Patent NZ-224241-A (NZ)
Title: Method of producing new animal breeds using plasmid expression vectors; plasmid expression vectors
Inventor: SEAMARK ROBERT FREDERICK
IPC: A01K67/027
Filed: 1988-04-13
Abstract: A method for creating new breeds of animals which comprises: (a) obtaining a recently fertilised ovum; (b) isolating a gene sample of a characterising hormone homologous with the ovum; (c) introducing the gene sample into the male nucleous of the ovum prior to fusion with the female nucleous to form a single cell embryo; and (d) subsequently implanting the ovum into a suitably prepared female animal. Wherein in a preferred method there is used a plasmid expression vector comprising a plasmid cloning vector including a first cloned sequence of DNA encoding a non-porcine promoter region and a second cloned sequence encoding porcine growth hormone activity.
Patent NZ-231955-A (NZ)
Title: Metallurgical vessel gas injection with purging plug raised above bottom lining
Inventor: WAGNER HERBERT
IPC: F27D3/16
Filed: 1989-12-21
Abstract: The present invention relates to a gas-flushing installation for introducing gases into metallurgical vessels, consisting of
 a) a gas-bubble brick (1), provided with gas-bearing channels (2), in the form of two superposed circular truncated cones, of which one concentrically surrounds the other, of refractory material,
 b) a metal layer (6) surrounding the outer and inner shell surfaces of the gas-bubble brick and its base surface (5),
 c) a gas feed (7) arranged centrally on the metal-coated base surface (5) of the gas-bubble brick (1) in the form of a circular truncated cone,
 d) two mutually separate chambers, of which the inner one bears gas and the outer one does not bear gas, and
 e) a perforated brick (8) surrounding the metal-coated shell surface of the gas-bubble brick (1) in the form of a circular truncated cone. 
<??>The invention is characterised in that the upper end (9), not surrounded by the perforated brick (8), of the truncated cone protrudes beyond the ladle bottom lining (10) into the interior of the ladle, and that the perforated brick (8) and the gas-bubble brick (1) seated therein are provided with an outer envelope (11) of cast or tamped refractory material. 
<IMAGE>
Patent NZ-232235-A (NZ)
Title: Blends of ethylene-vinyl alcohol copolymer and amorphous polyamide; films and multi-layered articles made therefrom
Inventor: CHOU RICHARD TIEN-HUA
IPC: C08J5/18
Filed: 1990-01-24
Abstract: Blends of a major portion of ethylene vinyl alcohol copolymer (EVOH) and a minor portion of an amorphous polyamide and preferably also a semicrystalline nylon are disclosed. These blends may be formed into films or multilayer structures, which can be thermoformed into containers or other articles. The presence of the minor portion of amorphous polyamide permits thermoforming of the EVOH at lower temperatures without the formation of defects.
Patent NZ-254675-A (NZ)
Title: Fluid delivery system, typically lpg, which shuts off delivery when a significant portion of vapour or gas is sensed by monitoring fluid dielectric characteristics
Inventor: CLARK JOHN KEITH
IPC: F17C13/02
Filed: 1993-08-09
Abstract: PCT No. PCT/AU93/00402 Sec. 371 Date Jan. 6, 1995 Sec. 102(e) Date Jan. 6, 1995 PCT Filed Aug. 9, 1993 PCT Pub. No. WO94/03755 PCT Pub. Date Feb. 17, 1994A system for delivering fluid, e.g. liquefied petroleum gas or "LPG", through a delivery path (10) under pressure. A delivery control valve (16) is selectably operable to close and open the delivery path (10) and monitors a parameter of the fluid, e.g. dielectric constant, and to sense the presence of vapor or gas phase in the fluid. A control means (30) responsive to the indicating signal from the sensing means (20) causes the delivery control valve (16) to close the delivery path upon sensing the presence of a significant proportion of vapor or gas phase in the fluid. A gas introduction point (35) upstream of the sensing means (20) enables gas to be introduced so as to knowingly expose the sensing means (20) to fluid containing gas phase and thereby enable controlled testing of the correct functioning of the sensing means (20). In the case of the fluid being liquefied gas, pumping means (45) upstream of the sensing means (20) can continue operation after closure of the delivery control valve (16) so that the gas or vapor phase will undergo compression and as a result will liquify and the control means (30) will then cause re-opening of the delivery control valve (16). The closure of the delivery control valve (16) prevents liquefied gas having a significant proportion of gas or vapor phase passing through a metering means (15) downstream of the sensing means (20).
Patent NZ-272088-A (NZ)
Title: Latch handle locking device for transport container: lock actuated by sensor that senses atmosphere composition in container
Inventor: BASINSKI EDWARD MCKARY
IPC: E05B65/16
Filed: 1995-05-09
Abstract: A device (10) for preventing the opening of a door (52) into an enclosed space (50) if the atmosphere in the space is hazardous. A sensor or sensors (31) monitor the atmosphere in the space and provide a controller (32) with a signal proportional to atmospheric conditions. If the controller determines that a hazardous condition exists, it produces a signal that actuates a lock that prevents the door from being opened. In a preferred embodiment, the device prevents the opening of a door of a transport container if the proportion of oxygen in the atmosphere of the interior of the container is less than a predetermined value.
Patent NZ-283155-A (NZ)
Title: Tea bag with drawstring (for wringing) passing through heat seal on periphery of bag
Inventor: CAHILL MICHAEL JOHN
IPC: B65D85/808
Filed: 1995-04-04
Abstract: To form infusion packets (T) having a looped thread (8) within the packets to wring moisture from the packet in use, a continuous series of thread loops are formed on one elongate web of packet material and doses of infusion material are placed on a second elongate web of packet material before bringing the webs together with the thread loops and infusion material between them. The two webs are then welded together and the individual packets are separated from the joined webs. <IMAGE>
Patent NZ-325525-A (NZ)
Title: Disposable pillow or cushion cover comprising an envelope of air and a moisture impermeable material
Inventor: PANG HIAN SENG
IPC: A47G9/02
Filed: 1997-01-04
Abstract: A disposable pillow or cushion cover (1) is formed by an envelope (2) of air- and moisture-impermeable material.  The envelope (2) encases the pillow or cushion (3) and provides an impermeable resting surface upon which a user may rest the head or other body part. The envelope contains a vent (11) to permit ingress and egress of air from the pillow or cushion (3). The envelope (2) also includes a sealable opening (9) to permit insertion and removal of the pillow or cushion (3).  A facing layer (4) of air-permeable material extends over the resting surface and is secured to the envelope (2) at spaced-apart locations to allow airflow and a degree of relative movement between the facing layer (4) and envelope (2)
Patent NZ-330111-A (NZ)
Title: medical gas mixture containing oxygen, carbon dioxide and optionally helium for the treatment and imaging of tumours
Inventor: GARRETT MICHAEL ERNEST
IPC: A61K33/00
Filed: 1998-04-02
Abstract: The use of a gas mixture comprising from 20% to 70% oxygen, from 1% to 8% carbon dioxide and the remainder being helium, in the preparation of inhalable substances for use in the imaging and/or treatment of tumours.
Patent NZ-331827-A (NZ)
Title: Tetrahydro-beta-cabroline compounds and their use as 5HT2B receptors
Inventor: AUDIA JAMES E
IPC: C07D471/10
Filed: 1997-03-24
Abstract: The application provides tetrahydro-b-carboline compounds having useful central nervous system activity of the formula I, where R1, R3 and R5 each are H or C1-3alkyl; R6 is H, C1-6alkyl, C2-6alkenyl, halo, haloC1-6alkyl, COR5, C1-10alkanoyl,C02R5', NO2, SR5 and OR5; n is 1, 2 or 3; n' is 1, 2 or 3, m is 1 or 2 and R5' is C1-4alkyl. Provided are formulations and methods for using the tetrahydro-b-carboline and related compounds.  Such compounds are particularly useful for the modulation of a 5-HT2B receptor.
Patent NZ-333211-A (NZ)
Title: Moisture detecting devices such as for diapers and diapers having such devices
Inventor: NISSIM OFER
IPC: G01N27/00
Filed: 1997-05-06
Abstract: The application relates to devices (particularly diapers) for monitoring wetness of a subject.  A pair of spaced electrodes (114) within an area subject to wetness couple non-conductively with a sensor (124) protected from wetness, and an alarm sounds in response to moisture decreasing the resistance between the electrodes (114).  For example the electrodes (114) project into the absorbent material of a diaper and extend along the inside of the diaper sheath (110) opposite a pouch on the outside of the sheath (110).  The pouch contains a sensor (124) capacitively coupled to the electrodes (114).
Patent NZ-504423-A (NZ)
Title: Composition having enhanced penetration capabilities and irritation reducing systems
Inventor: MAK VIVIEN H W
IPC: A61K9/06
Filed: 1998-11-09
Abstract: A composition for topical application having penetration-enhancing properties comprising: a) an active agent selected from testosterone, estradiol and derivatives thereof; and b) a penetration-enhancing system comprising; i)  oleic acid; ii)  a C1-C4 alcohol; and iii)  a glycol, said composition having a pH value between about 4 to about 8.
Patent NZ-504614-A (NZ)
Title: Echinocandin derivatives and application as anti-fungal agents
Inventor: FAUVEAU PATRICK
IPC: C07K5/12
Filed: 1998-12-09
Abstract: Use of novel echinocandin derivatives of formula (I) wherein the substituents are defined within, for the treatment of fungal infections.
Patent NZ-505272-A (NZ)
Title: Blister pack for powder substances or medicaments with inhalation suction tube
Inventor: VON SCHUCKMANN ALFRED
IPC: A61M15/00
Filed: 1998-12-22
Abstract: A device for inhaling powdered medicament from the cavities (6) of a blister pack (8).  The upper surface of the pack (8) is covered by foil (5).  The powdered medicament is released by puncturing the blister pack covering foil (5) by using the suction tube (3) directly connected to the pack (8).  The contents are emptied via the suction tube (3) and, or inhaled using the tube (3).
Patent NZ-505290-A (NZ)
Title: Pharmaceutical compositions comprising cross-linked polymers loaded with drugs prepared by using supercritical fluids to solubilize and load the drugs on to the polymers
Inventor: CARLI FABIO
IPC: A61K9/16
Filed: 1998-11-16
Abstract: Pharmaceutical compositions in powder form are prepared by loading drugs solubilized in supercritical fluids on cross-linked polymers.  The loading process is carried out by means of two steps.  In the first step the supercritical fluid is saturated with the drug in suitable temperature and pressure conditions.  In the second step the supercritical fluid containing the drug is contacted with the cross-linked polymer.  Owing to its particular properties the supercritical fluid penetrates into the polymer and allows the drug to impregnate the polymer itself.  After the removal of the fluid the drug remains in the polymer itself.
Patent NZ-506228-A (NZ)
Title: Paper structures having a decorative pattern and method for making
Inventor: TROKHAN PAUL DENNIS
IPC: D21F11/00
Filed: 1999-02-03
Abstract: A paper web and method of making the paper web are disclosed. The paper web has a background portion and a non-embossed decorative pattern. The decorative pattern has at least one high basis weight region having a basis weight greater than the average basis weight of the surrounding background portion. The decorative pattern can include a number of discrete, decorative indicia. Each decorative indicia can be separated from adjacent decorative indicia by the background portion.
Patent NZ-509079-A (NZ)
Title: Proteins and nucleic acids encoding the same with homology to venom protein A
Inventor: GURNEY AUSTIN L
IPC: C07K14/705
Filed: 1999-06-02
Abstract: An antibody to IL-1b has an antigen binding specificity for an antigenic epitope of mature human IL-1b, includes the loop comprising residues Gly 22, Pro 23, Tyr 24 and Glu 25 and is capable of inhibiting the binding of IL-1b to its receptor. Preferably the antibody comprises an antigen binding site comprising at least one immunoglobin heavy chain variable domain (VH) which comprises in sequence hypervariable regions CDR1, CDR2 and CDR3 as shown in SEQ ID NO:1, i.e. CDR-1 having the amino acid sequence Ser-Tyr- Trp-Ile-Gly , CDR2 having the amino acid sequence Ile-Ile- Tyr-Pro-Ser-Asp-Ser-Asp-Thr-Arg-Tyr-Ser-Pro-Ser-Phe-Gln-Gly and the CDR 3 having the amino acid sequence Tyr-Thr-Asn- Trp-Asp-Ala-Phe-Asp-Ile. The antibody can be used in the manufacture of a medicament for the prevention or treatment of a an IL-mediated disease or disorder, allergies and allergic conditions, hypersensitivity reactions, autoimmune diseases, severe infections, organ or tissue transplant rejection; autoimmune disease, arthritis, rheumatoid arthritis, arthritis chronica progrediente, arthritis deformans, rheumatic diseases, inflammatory pain, hypersensitivity, airways hypersensitivity, dermal hypersensitivity, allergies, haematological disorders, hemolytic anaemia, aplastic anaemia, pure red cell anaemia, idiopathic thrombocytopenia, systemic lupus erythematosus, polychondritis, sclerodoma, Wegener granulomatosis, dermatomyositis, chronic active hepatitis, myasthenia gravis, psoriasis, Steven-Johnson syndrome, idiopathic sprue, autoimmune inflammatory bowel disease, ulcerative colitis, Crohn's disease, Irritable Bowel Syndrome, endocrine ophthalmopathy, Graves disease, sarcoidosis, multiple sclerosis, primary biliary cirrhosis, juvenile diabetes, diabetes mellitus type I, uveitis (anterior and posterior), keratoconjunctivitis sicca, vernal keratoconjunctivitis, interstitial lung fibrosis, psoriatic arthritis and glomerulonephritis, idiopathic nephrotic syndrome or minimal change nephropathy, asthma, bronchitis, pneumoconiosis, pulmonary emphysema, and other obstructive or inflammatory diseases of the airways, acute and hyperacute inflammatory reactions, acute infections, septic shock, endotoxic shock, adult respiratory distress syndrome, meningitis, pneumonia; and severe burns, cachexia or wasting syndrome, cancer, organ dysfunction, AIDS- related cachexia, diseases of bone metabolism, osteoarthritis, osteoporosis and other inflammatory arthritides, bone loss in general, age-related bone loss, periodontal disease, cancers, and IL-1-dependent tumours. Also described is a DNA construct that encodes a heavy chain which comprises a first part which encodes a variable chain comprising alternatively framework and hypervariable regions and a second part encoding a heavy chain constant part, and another DNA constant encoding a light chain.
Patent NZ-512600-A (NZ)
Title: Dosing and delivering system
Inventor: CANN DAVID VICTOR
IPC: A61M11/00
Filed: 2000-01-12
Abstract: The present device relates to a dispensing device (1) for a fluid (10), the dispensing device (1) comprising a reservoir (11), a shaft (12), a back seal (13), a damper (14), a piston (151) and a one-way valve (16), the back seal (13) sealing a first end of the reservoir and being displaceable along the shaft, the valve being on the second end of the reservoir, the piston being fixed to one end of the shaft, the piston being located between the valve and the damper, the damper being also fixed to the shaft, the damper being located between the piston and the back seal, whereby the piston has an opened position (151) and a closed position (152), the open position allowing fluid communication between the valve and the part of the reservoir between the piston and the back seal, the displacement of the piston between the opened and the closed position being induced by a displacement of the shaft along its own axis, the pressure in the area comprised between the valve and the piston reducing when the piston is moved from its closed position towards its opened position, the damper collapsing when the piston is moved from its closed position towards its opened position, the only fluid flow from the part of the reservoir situated between the damper and the back seal and the part of the reservoir situated on the other side of the damper being a connecting passage (140) situated in the damper (14) when the piston is moved from its opened position towards its closed position.
Patent NZ-515534-A (NZ)
Title: System and method for influencing a position on a search result list generated by a computer network search engine
Inventor: DAVIS DARREN J
IPC: G06F17/30
Filed: 2000-05-26
Abstract: A system and method for enabling information providers to influence position for a search listing within a search result list generated by an Internet search engine. The network information provider may add, delete, or modify a search listing after logging via an authentication process (110). The information provider influences a position for a search listing in the provider's account by first selecting a search term relevant to the content of the web site. The network information provider enters the search term and the description into a search listing. The information provider influences the position for a search listing through a continuous online competitive bidding process (170). The bidding process occurs when the information provider enters a new bid amount for a search listing. This system and method then compares this bid amount with all other bid amounts for the same search term, and generates a rank value for all search listings having that search term. The rank value generated by the bidding process determines where the information providers listing will appear on the search results list page that is generated in response to a query of the search term by a searcher located at a client computer on the network (170).
Patent NZ-532490-A (NZ)
Title: Access fitting for tank
Inventor: TRAIL MARK EDWARD
IPC: F16L39/00
Filed: 2004-04-23
Abstract: An access fitting for a tank having a head flange and a hollow shank extending from the head flange. The shank has a proximal threaded portion adjacent the flange and a distal screw threaded portion remote from the head flange characterized in that there is provided an intermediate unthreaded portion between the proximal and distal portions which in use may be engaged by a toll to prevent rotation of the shank.
Patent NZ-534377-A (NZ)
Title: Water-based topical delivery system consisting of cholesterol, fatty acids water and a phospholipid/ceramide portion.
Inventor: SKOLD THOMAS
IPC: A61K8/63
Filed: 2003-03-13
Abstract: Disclosed is a water-based topical delivery system for an active substance, capable of enhancing skin barrier restoration in the stratum corneum comprising water; fatty acids; cholesterol; and a ceramide/phospholipids portion wherein the ceramide/phospholipids portion comprises at least 5% phospholipids, wherein the ratio of ceramide/phospholipids portion: cholesterol; fatty acid is approximately between 2:1:1 and 2.35:1:1.
Patent NZ-537508-A (NZ)
Title: Plug assembly for a faucet to automatically stop water flow
Inventor: KAO YU-YUEH
Filed: 2005-01-05
Abstract: Plug assembly to automatically stop water flow from a faucet A plug assembly, to automatically stop water flow from a faucet, comprises a casing 10, a cylinder (20 figure 2) received in the casing 10, an isolator 40, a top ring 50, a control rod 60, a push rod 70 and an adjusting device. In use, the casing 10 is screwed into a faucet and water is prevented from flowing through a hole 51 in the top ring 50 by a sealing ring 91. Moving the push rod 70 upwards causes a friction ring 80, the control rod 60, sealing ring 91 and a screw 90 to be moved upwards relative to the top ring 50 (see figure 4). This opens a gap between the sealing ring 91 and the top ring 50, and allows water to flow through hole 51 and out through the assembly. Water pressure applied to a head of the screw 90 and the sealing ring 91 gradually cause the control rod 60 and push rod 70 to move downwards, overcoming a frictional force between the friction ring 80 and an inner periphery of a through hole 41, until sealing ring 91 blocks the flow of water through hole 51. The duration for which water is allowed to flow can be adjusted by turning screw 90, such that the deformation of friction ring 80 between an annular stop 63 and the push rod 70 is varied. A consequent variation in the friction between the friction ring 80 and the inner periphery of the through hole 41 increases or decreases flow duration.
Patent NZ-538992-A (NZ)
Title: Devices, systems and methods for thawing, heating and/or glazing previously frozen baked goods or dough-based products
Inventor: PETERSON LARRY
IPC: A21D17/00
Filed: 2003-09-30
Abstract: Devices, systems and methods for thawing, heating and/or glazing previously frozen baked goods and other dough-based products, wherein the products can be thawed in an environment having a selected temperature and elevated humidity; the conveyor is configured to prevent early and excessive insertion of the products into the oven; the oven is configured to heat the products to greater than a selected surface temperature; and wherein the glazer is configured to apply glaze to the products when the surface temperature of the product is within a desired range.
Patent NZ-539520-A (NZ)
Title: Biocompatible cross-linked polymer matrices, and methods of making and using same
Inventor: ELISSEEFF JENNIFER
IPC: C08J3/28
Filed: 2003-09-25
Abstract: Functionalized chrondroitin sulfate, cross-linked polymer matrices comprising functionalized chrondroitin sulfate, and methods of making and using the same are disclosed. Such polymer matrices may be used for tissue engineering, reconstructing cartilage, and the like. Kits are also provided for detection of cartilage degrading enzymes.
Patent NZ-539735-A (NZ)
Title: Diagnosis and monitoring of diseases using markers, such as diketopiperazines
Inventor: BAR-OR DAVID
IPC: A01N37/18
Filed: 2003-10-02
Abstract: Disclosed is a method for diagnosing and monitoring a disease or condition by quantifying markers, wherein said marker is: (i) a truncated disease-associated protein lacking its two N-terminal amino acids and lacking only these two amino acids from the N-terminus; (ii) a truncated disease-associated protein lacking its two C-terminal amino acids and lacking only these two amino acids from the C-terminus; (iii) a truncated disease-associated protein lacking its two N-terminal amino acids and its two C-terminal amino acids and lacking only these two amino acids from the N-terminus and two amino acids from the C-terminus; (iv) a diketopiperazine (DKP) comprising the two N-terminal amino acids of a disease-associated protein, wherein the DKP is not His-Pro DKP; or (v) a DKP comprising the two C-terminal amino acids of a disease associated protein wherein the disease associated protein is myelin basic protein, beta amyloid, Rh factor, pulmonary surfactant associated protein A, pulmonary surfactant associated protein B, pulmonary surfactant associated protein D, insulin, tau protein, alpha synuclein, C reactive protein, interleukin 8, S100 proteins, beta chorionic gonadotropin, fetal erythropoietin, pregnancy associated protein A, myoglobin, troponin I, troponin T, prostate specific antigen, amylase, lipase, alpha1 antitrypsyn, erthyropoietin, activated protein C, tethal chain, zeta chain, alpha chain, beta chain, delta chain, epsilon chain, or gamma AG. Also disclosed are binding partners specific for the markers and compositions and kits for conducting the methods of the invention.